Addison Capital’s Gilead Sciences GILD Stock Holding History

Addison Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,010	Closed	-$71K	–	134
2021 Q3	$71K	Buy	+1,010	New	+$71K	0.03%	123
2015 Q3	–	Sell	-1,710	Closed	-$200K	–	90
2015 Q2	$200K	Buy	+1,710	New	+$187K	0.18%	80

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Addison Capital's GILD Position: Q4 2021 in Review

Addison Capital sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 1,010 shares — an estimated $71K sold.

Addison Capital first reported a position in GILD in Q2 2015 and held it in 2 quarters. The position peaked at $200K in Q2 2015. 1,682 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

Addison Capital reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
Addison Capital sold 1,010 Gilead Sciences shares in Q4 2021, an estimated $71K.
Addison Capital first reported a position in Gilead Sciences in Q2 2015 and held it in 2 quarters.
Addison Capital's Gilead Sciences position peaked at $200K in Q2 2015.
1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Addison Capital's 13F filing for Q4 2021, filed 18 Jan 2022.